Articles
Safety and general analysis, written plainly
Shorter pieces sitting alongside our compound reviews: what to do when something goes wrong, how to monitor yourself properly, and how to read the documents and reviews this market runs on.
Safety
17 articlesSafety
Red-flag symptoms: when a side effect stops being a side effect
Most reported effects of performance-enhancing drug use are unpleasant but not dangerous. A smaller set indicates organ injury and needs same-day medical assessment. Knowing the difference is the most useful safety skill in this area.
6 min read · updated 2026-09-10
Safety
Baseline bloodwork: what to test, and why a single panel proves little
Bloodwork is the only way most of the harms documented in the literature become visible before symptoms appear. Its value comes from comparison over time, which means a pre-use baseline is worth more than any single later result.
7 min read · updated 2026-09-10
Safety
Injection practice: the harm that has nothing to do with the compound
A significant share of hospital presentations linked to injectable performance-enhancing drug use are infections and injection-site injuries rather than drug effects. These harms are procedural, well documented, and largely avoidable.
6 min read · updated 2026-09-11
Safety
Stacking: why combined risk is not the sum of its parts
Almost every published human study covers one compound at a time. Almost every real-world protocol combines several. That gap is where most of the uncertainty in this field actually sits.
5 min read · updated 2026-09-11
Safety
Mental health: the effects users are least likely to notice in themselves
The psychiatric effects of anabolic steroid use are among the better-documented findings in the human literature, and among the least discussed. They are also the effects the person experiencing them is worst placed to identify.
6 min read · updated 2026-09-12
Safety
Fertility after androgen use: recovery is not a switch
Androgen use can suppress the signals needed for sperm production. Recovery varies between people, and feeling normal is not the same as having recovered fertility.
7 min read · updated 2026-09-23
Safety
Heart health: why a strong workout is not a cardiac check
Exercise capacity and apparent fitness can coexist with changes in blood pressure, cholesterol and heart structure. Looking well is not a cardiovascular test.
7 min read · updated 2026-09-23
Safety
Liver test abnormalities: exercise effects are not an all-clear
Hard training can change some blood markers also used to investigate liver injury. That overlap makes context important, but it must never be used to dismiss warning signs.
6 min read · updated 2026-09-23
Safety
Product contamination and sterility: two different safety questions
A product can contain the wrong drug, a different quantity, or microorganisms. Chemical testing and sterility testing answer different questions; neither is implied by an attractive label.
7 min read · updated 2026-09-23
Safety
Sleep, stimulants and training: fatigue is not a nuisance variable
A stimulant may make a tired session feel easier without undoing lost sleep. In performance-drug discussions, sleep disruption deserves attention as its own health signal.
6 min read · updated 2026-09-23
Safety
Haematocrit: why thicker blood is a quiet risk
Androgens raise red blood cell production. A high haematocrit rarely causes symptoms early, which is why it is easy to miss.
6 min read · updated 2026-10-02
Safety
Blood pressure at home: the simplest check most people skip
Androgens, stimulants and some peptides can raise blood pressure. Home readings, taken properly, catch changes early.
5 min read · updated 2026-10-02
Safety
Kidney tests in muscular people: creatinine needs context
High muscle mass and creatine supplements raise creatinine, but genuine kidney injury has also been reported with androgen use.
6 min read · updated 2026-10-02
Safety
Gynaecomastia: what drives it and why waiting can matter
Breast tissue growth reflects a shift in the oestrogen–androgen balance. Early tissue can regress; long-standing tissue often does not.
6 min read · updated 2026-10-02
Safety
Women and androgens: some changes do not reverse
SARMs and steroids marketed as 'female-friendly' still act on androgen receptors. Voice and hair changes can be permanent.
6 min read · updated 2026-10-02
Safety
Buying SARMs in Australia: an independent buyer's safety guide
Searching to buy SARMs in Australia? Before choosing a supplier, understand what independent testing has found inside products sold online, and how to vet a seller.
8 min read · updated 2026-10-02
Safety
Buying peptides in Australia: purity, storage and supplier checks
Looking to buy BPC-157, TB-500 or other peptides in Australia? Purity, sterility and cold-chain handling matter as much as the peptide itself.
7 min read · updated 2026-10-02
General
13 articlesGeneral
How we grade evidence, and why most compounds score low
Every review we publish carries an evidence grade. The grade describes the quality of the human research behind a compound, not how effective users believe it to be — and for most of this field, the honest grade is low.
5 min read · updated 2026-09-08
General
Reading a certificate of analysis without being misled by one
A certificate of analysis is the only practical evidence a buyer gets about what is in a product. It is also easy to present in a way that proves far less than it appears to.
7 min read · updated 2026-09-08
General
Why vendor reviews mislead, and how we weigh them
Review counts are the metric buyers lean on most and the one most easily manufactured. Where a review is hosted determines how much it is worth, and some claimed figures collapse under a single check.
6 min read · updated 2026-09-09
General
Mislabelled and substituted products: what analytical studies found
The most consistent finding in the analytical literature on this market is that labels are unreliable. It undermines every other safety measure, because a dose you cannot verify is a dose you cannot manage.
6 min read · updated 2026-09-09
General
Community reports versus published evidence: using both without confusing them
Community experience often identifies a problem years before the literature does. It also cannot establish cause, frequency or magnitude. We publish both, kept clearly apart, because each answers a question the other cannot.
6 min read · updated 2026-09-12
General
How to read a clinical trial without borrowing its conclusions
The headline result of a trial is only useful after you ask who participated, what was measured and whether the finding applies to the people and products being discussed.
7 min read · updated 2026-09-23
General
Animal studies versus human outcomes: where the translation breaks
A compound that changes a mouse's endurance or a rat's muscle mass has not been shown to do the same thing safely in a person. Preclinical results are a starting hypothesis, not a consumer claim.
6 min read · updated 2026-09-23
General
Vendor policies: useful consumer signals, not proof of product quality
Shipping, refunds and money-back promises matter when comparing sellers. They tell you about a transaction, however, not whether a product contains the substance on its label.
6 min read · updated 2026-09-23
General
Conflicts of interest: reading the funding line before the conclusion
A funding relationship does not automatically make a study wrong. It does mean readers should look more closely at design, outcome selection and how strongly the conclusions match the data.
6 min read · updated 2026-09-23
General
Product, batch and report: the three-way match behind a useful test
A laboratory document is relevant only if it can be connected to the product actually purchased. Matching names, lots and dates is essential, yet even that cannot prove every unit is identical.
6 min read · updated 2026-09-23
General
'Research use only': what the label does and does not tell you
A research-chemical label is a sales and legal framing. It says nothing about purity, sterility or suitability for human use.
5 min read · updated 2026-10-02
General
Half-life claims: why one number on a product page misleads
Half-life varies with formulation, route and person. A single figure copied across vendor sites is rarely sourced.
5 min read · updated 2026-10-02
General
Best SARMs and peptide suppliers in Australia: how to judge them yourself
'Best' lists are usually affiliate marketing. Here is the transparent checklist we use to rank Australian SARMs and peptide suppliers, so you can apply it yourself.
6 min read · updated 2026-10-02
These articles are educational. They are not medical advice, a dosing recommendation, or an endorsement of use. Speak with a qualified medical practitioner about your circumstances.